FORMATION OF SUPPLY CHAIN RESILIENCE IN THE PHARMACEUTICAL MARKET
Abstract
The article examines the issue of supply chain resilience in Ukraine's pharmaceutical market under martial law. Pharmaceutical supply chains are considered critical infrastructure, exerting a direct influence on national security, healthcare stability, and medicine availability. In the context of armed conflict, conventional management methodologies become ineffective due to a multitude of factors, including infrastructure destruction, disrupted logistics, energy instability, and shifts in medicine demand. The study reviews contemporary approaches to resilience assessment, including risk-oriented management, logistics digitalization, and adaptive strategies. It notes that most models are designed for stable conditions and do not sufficiently consider risks specific to warfare, such as supply disruptions, cold chain failures, and delays. An authorial approach defines resilience as the system's ability to anticipate, prevent, adapt to, and recover from military and logistics risks. FMEA is a method used to quantify risks in leading pharmacy chains, thereby identifying critical threats. The enhancement of resilience can be achieved through a variety of strategies, including supplier diversification, the implementation of alternative logistics routes, the maintenance of safety stocks, and the utilization of digital monitoring systems.
References
Dienes B. B., Qorri D., et al. (2022) Resilience strategies in pharmaceutical supply chains: A systematic review. Journal of Supply Chain Management, vol. 58(3), pp. 112–129. Available at: https://doi.org/10.1002/jscm.2204 (accessed February 9, 2026).
Gupta H., Kayande R. A. (2021) Adaptive supply chain management in pharmaceutical companies during COVID-19: Evidence from multiple geographies. International Journal of Operations & Production Management, vol. 41(7), pp. 987–1005. Available at: https://doi.org/10.1108/IJOPM-08-2020-0536 (accessed February 9, 2026).
Zhao X., Smith J., Lee Y. (2020) Simulation-based assessment of resilience in regional pharmaceutical supply chains. Computers & Industrial Engineering, vol. 147, 106655. Available at: https://doi.org/10.1016/j.cie.2020.106655(accessed February 9, 2026).
Li H., Chen R., Wang S. (2019) Mathematical modeling of pharmaceutical supply chain resilience under global risks. Computers & Chemical Engineering, vol. 126, pp. 106–118. Available at: https://doi.org/10.1016/j.compchemeng.2019.03.015 (accessed February 9, 2026).
Papalexi M., Vafadarnikjoo A., Bamford D., et al. (2021) Industry 4.0 technologies for adaptive pharmaceutical supply chains. Technological Forecasting and Social Change, vol. 167, 120712. Available at: https://doi.org/10.1016/j.techfore.2021.120712 (accessed February 9, 2026).
Nechyporuk A., Kochubei D. (2023) Pharmaceutical logistics under martial law in Ukraine: Risks and adaptive strategies. Ukrainian Journal of Logistics and Supply Chain Management, vol. 5(1), pp. 45–60. Available at: https://doi.org/10.21272/ujlscm.2023.5.1-4 (accessed February 9, 2026).
Kochubei D. (2022) Theoretical framework for supply chain network management in pharmaceutical distribution. Eastern European Journal of Business and Economics, vol. 3(2), pp. 23–38. Available at: https://doi.org/10.29040/eejbe.v3i2.212 (accessed February 9, 2026).
Lisna A. H., Posilkina O. V. (2021) Digitalization of healthcare pharmaceutical supply systems: Efficiency and resilience. Journal of Healthcare Engineering, vol. 2021, 6678482. Available at: https://doi.org/10.1155/2021/6678482(accessed February 9, 2026).
Lisna A. H., Posilkina O. V. (2022) Innovative digital solutions for pharmaceutical supply chains. International Journal of Medical Informatics, vol. 163, 104795. Available at: https://doi.org/10.1016/j.ijmedinf.2022.104795 (accessed February 9, 2026).
Krykavskyy Y., Chornopyska N., et al. (2023) Methodological approaches to assessing pharmaceutical chain resilience during wartime. Ukrainian Journal of Logistics and Supply Chain Management, vol. 6(2), pp. 12–30. Available at: https://doi.org/10.21272/ujlscm.2023.6.2-2 (accessed February 9, 2026).
Quality Matters.Global manufacturing capacity for active pharmaceutical ingredients remains concentrated. Available at: https://qualitymatters.usp.org/global-manufacturing-capacity-active-pharmaceutical-ingredients-remains-concentrated#:~:text=India%20accounts%20for%2048%25%2C%20which,decrease%20from%2010%25%20in%202021 (accessed February 19, 2026).
Proxima. Pharmacysales for the first 9 months of 2024. Available at: https://proximaresearch.com/ua/en/news/pharmacy-sales-for-the-first-9-months-of-2024/#:~:text=Consumption%20Structure,for%20antidiabetic%20drugs%20and%20antibiotics.(accessed February 9, 2026).
Copyright (c) 2026 Наталія Ільченко, Олексій Становий
This work is licensed under a Creative Commons Attribution 4.0 International License.
